HIGH
CVE-2026-30994
CWE-284Published: April 15, 2026· Updated: Apr 17, 2026
7.5
CVSS v3.1
EPSS:0.04%probability of exploitation in 30 daysPercentile:13.5th
Official Description
Incorrect access control in the config.php component of Slah v1.5.0 and below allows unauthenticated attackers to access sensitive information, including active session credentials.
Technical Analysis
CVE-2026-30994 can be exploited remotely over the network without requiring physical or adjacent access, significantly expanding the attack surface for threat actors.
The vulnerability requires no privileges and no user interaction, making it a prime target for automated exploitation campaigns and worm-like propagation.
A successful exploit results in complete confidentiality breach (data exposure), with a CVSS base score of 7.5.
CVSS v3.1 Vector Breakdown
Exploitability
Attack VectorNetwork
Attack ComplexityLow
Privileges Req.None
User InteractionNone
ScopeUnchanged
Impact
ConfidentialityHigh
IntegrityNone
AvailabilityNone
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N
Affected Vendors & Products
Mentioned vendors (from description):
PHP
CPE data not yet available in NVD for this CVE.
Exploit & PoC Resources
NO KNOWN EXPLOITNo public exploit confirmed at this time
Exploit-DB
Offensive Security exploit database
GitHub PoC Search
Community PoC repositories
Rapid7 / Metasploit
Metasploit module search
PacketStorm
Security advisories & exploits
NVD Detail
Official NIST entry
MITRE CVE
CVE Program entry
External links open in a new tab. Always verify in a controlled environment before use.
All References (2)
Quick Facts
CVE IDCVE-2026-30994
CVSS Score7.5 / 10
SeverityHIGH
WeaknessCWE-284
CISA KEVNo
EPSS (30d)0.04%
PublishedApr 15, 2026
Related CVEs (CWE-284)
Recommended Actions
- →Apply vendor patches immediately
- →Monitor CVE-2026-30994 in threat intel feeds
- →Review IDS/IPS signatures for exploitation attempts
Data sourced from NVD (NIST), CISA KEV, and EPSS (FIRST). Analysis generated by CTIWATCH.COM. CVE data is provided under the NVD usage policy.